NASDAQ:HILS

Hillstream BioPharma - HILS News Today

$0.79

-0.06 (-7.05%)

(As of 03/31/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.77
▼
$0.87
50-Day Range: $0.48
▼
$1.89
52-Week Range: $0.30
▼
$2.78

Volume: 101,724 shs
Average Volume: 165,902 shs
Market Capitalization: $9.11 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

Get Hillstream BioPharma News Delivered to You Automatically

HILS Media Mentions By Week

HILS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HILS
News Sentiment
▼
-0.33

0.36
▲
Average
Medical
News Sentiment

HILS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HILS Articles
This Week
▼
2

0
▲
HILS Articles
Average Week

Source

Source	Headline
	Hillstream BioPharma to Participate in Two Major Industry Conferences in April 2023 finance.yahoo.com - March 28 at 10:38 AM
	Dawson James Weighs in on Hillstream BioPharma, Inc.'s Q2 2023 Earnings (NASDAQ:HILS) americanbankingnews.com - March 23 at 7:14 AM
	Hillstream BioPharma to Attend the 35th Annual ROTH Conference on March 12-14, 2023 finance.yahoo.com - February 28 at 8:02 PM
	Hillstream BioPharma Regains Compliance with Nasdaq Listing Minimum Bid Price Rule finance.yahoo.com - February 15 at 8:56 AM
	Hillstream BioPharma Provides Webcast for its R&D Day on February 14th, 2023 at 10:00am ET finance.yahoo.com - February 13 at 8:25 PM
	Hillstream BioPharma Signs Exclusive Option Agreement with Applied Biomedical Science Institute (ABSI) to License Technology for HER2 and HER3 to be Developed for Potential Treatments Against Drug Resistant Cancers Including HER2-Positive Metastatic Breast Cancer, Gastric Cancer, Lung Cancer and Ovarian Cancer finance.yahoo.com - February 13 at 10:24 AM
	Hillstream Nearly Doubles on Test Results baystreet.ca - February 10 at 12:41 PM
	Hillstream Soars on Promising HSB-1216 Data in Lung Cancer msn.com - February 10 at 12:41 PM
	In a KRAS G12C-mutated NSCLC cell line, Calu-1, Hillstream BioPharma Demonstrated Significantly Greater Tumor Inhibition Combining Pembrolizumab, an anti-PD-1 antibody, and HSB-1216, a Ferroptosis Inducer finance.yahoo.com - February 10 at 7:34 AM
	Hillstream BioPharma Announces Acceptance of Abstract at AACR 2023 Annual Meeting Highlighting HSB-510 as Novel Bi-functional Inhibitor for Solid Tumors & Leukemias finance.yahoo.com - February 8 at 8:42 AM
	Hillstream BioPharma to Host Virtual R&D Day to Showcase its Emerging Immuno-oncology Pipeline Targeting Drug-Resistant Cancers finance.yahoo.com - February 6 at 9:46 AM
	Why Are Hillstream BioPharma Shares Trading Over 100% Today? finance.yahoo.com - January 31 at 2:47 PM
	Hillstream BioPharma Signs an Exclusive Option Agreement to Advance Next-Generation Anti-MUC1-C Agents for Drug Resistant Cancers finance.yahoo.com - January 31 at 9:46 AM
	Hillstream BioPharma to Present at the Virtual Sidoti Micro-Cap Conference on January 18-19, 2023 finance.yahoo.com - January 17 at 4:04 PM
	Insiders who purchased Hillstream BioPharma, Inc. (NASDAQ:HILS) stock last year recover some losses which currently stand at US$86k finance.yahoo.com - December 12 at 7:20 AM
	Hillstream BioPharma Announces Development of Proprietary Targeted Biologics, Knob Quatrabodies™ (HSB-1940) against PD-1, by combining Quatramers™ with OmniAb’s Picobodies™, via a Collaboration Agreement, against Novel, Unreachable and Undruggable Epitopes in High Value Validated Targets finance.yahoo.com - December 1 at 9:17 AM
	Hillstream’s New Anti-Cancer Mechanism Quatramer-based Ferroptosis Inducer, HSB-1216 Abstract Available for Viewing at EORTC-NCI-AACR Symposium finance.yahoo.com - October 18 at 6:14 PM
	Hillstream BioPharma, Inc. to Present at Upcoming Investor Conferences finance.yahoo.com - October 6 at 11:03 AM
	Hillstream BioPharma, Inc. (HILS) finance.yahoo.com - September 21 at 10:10 PM
	Hillstream BioPharma to Participate in the Fierce... benzinga.com - September 16 at 10:59 AM
	Hillstream BioPharma to Participate in the Fierce Biotech Summit on September 19-20 finance.yahoo.com - September 14 at 12:26 PM
	Hillstream BioPharma to Attend the 12th Annual World Orphan Drug Congress USA on July 11-13 finance.yahoo.com - July 8 at 10:31 AM
	A number of insiders bought Hillstream BioPharma, Inc. (NASDAQ:HILS) stock last year, which is great news for shareholders finance.yahoo.com - July 4 at 9:05 PM
	Hillstream BioPharma Announces Collaboration with Sapien Biosciences in Cancer Treatments finance.yahoo.com - June 27 at 8:39 AM
	Why Hillstream BioPharma Shares Are Trading Higher Today? finance.yahoo.com - June 13 at 4:24 PM
	Hillstream Biopharma pops 55% premarket on $1M share repurchase program seekingalpha.com - June 13 at 11:23 AM
	Hillstream BioPharma Announces Share Repurchase Program finance.yahoo.com - June 13 at 11:23 AM
	Hillstream BioPharma to Present at BioNJ's 12th Annual BioPartnering Virtual Conference Held on May 9- 13, 2022 finance.yahoo.com - May 5 at 11:13 AM
	Hillstream BioPharma R&D Day Highlights Ferroptosis, the tmcnet.com - March 2 at 9:00 PM
	Hillstream BioPharma R&D Day Highlights Ferroptosis, the Non-Genetic Novel, Emerging Mechanism of Action, Targeting Drug Resistant and Devastating Cancers finance.yahoo.com - March 2 at 9:00 PM
	Hillstream BioPharma nabs FDA’s Orphan Drug Designation for eye cancer therapy seekingalpha.com - February 18 at 5:40 AM
	Hillstream BioPharma Receives Orphan Drug Designation for HSB-1216 for the Treatment of Uveal Melanoma finance.yahoo.com - February 16 at 10:06 AM
	Hillstream Biopharma Granted Orphan Designation For Treatment Of Uveal Melanoma benzinga.com - February 15 at 7:05 PM
	Hillstream BioPharma Provides Business Review with Key Pipeline Updates finance.yahoo.com - February 14 at 12:53 PM
	SAVE THE DATES: Hillstream BioPharma Announces R&D Day on February 24, 2022 and Business Review on Monday February 14, 2022 finance.yahoo.com - February 11 at 9:12 AM
	Hillstream BioPharma Announces Acceptance of Abstract at AACR 2022 Annual Meeting Highlighting HSB-510, a Novel Quatramer-based, First-in-Class Dual Inhibitor of HDAC6 and PI3K-delta Downregulating c-myc Expression finance.yahoo.com - February 1 at 12:00 PM
	Hillstream BioPharma and University of Massachusetts Chan Medical School Announce Research Collaboration using CRISPR and Computational Approaches to Advance The Hillstream Ferroptomic Atlas finance.yahoo.com - January 26 at 2:05 PM
	Hillstream BioPharma Inc Shares Close the Day 21.0% Lower - Daily Wrap nasdaq.com - January 14 at 11:00 PM
	Hillstream BioPharma Announces Closing of Initial Public Offering finance.yahoo.com - January 14 at 5:59 PM
	Hillstream BioPharma, Inc. Common Stock (HILS) ca.finance.yahoo.com - January 13 at 10:26 PM
	Justworks IPO Postponed investopedia.com - January 13 at 5:26 PM
	Hillstream BioPharma Announces Pricing of Initial Public Offering finance.yahoo.com - January 13 at 5:26 PM
	Hillstream BioPharma prices upsized 3.75M-share IPO below range at $4 seekingalpha.com - January 13 at 5:26 PM

Get Hillstream BioPharma News Delivered to You Automatically

This page (NASDAQ:HILS) was last updated on 4/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Hillstream BioPharma - HILS News Today

HILS Media Mentions By Week

HILS Media Sentiment

HILS News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info